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ANALYSIS
In 2006 the Netherlands introduced a set of 
healthcare reforms aimed at improving the 
efficiency of the country’s health system and 
getting better value for money. Dutch society, 
in common with that of many other Euro-
pean countries, is ageing and healthcare costs 
are expected to peak in 2040. The Dutch 
ministry of health thought that change was 
essential if the system was to contain costs 
and continue to provide equitable access to 
good quality care. The reforms have attracted 
much interest, not least in the US, because 
the Dutch are trying to make private insur-
ance work for public benefit. We describe the 
reforms, explain why they were introduced, 
and discuss early evidence of their effect.
Spur for health reforms
The seeds for the 2006 reforms were sown in 
the late 1980s. In 1987 a committee, headed 
by the chief executive of Philips, Wisse 
Dekker, reported that the system lacked effi-
ciency.1 The Dekker report pointed to a lack 
of cost awareness among consumers and pro-
viders and a fragmented funding system, with 
lack of alignment between the publicly and 
privately funded parts of the system. It also 
concluded that rigid governmental regulation 
inhibited flexible organisation and thwarted 
innovation.
Before the reforms, around two thirds of 
the Dutch population was covered by social 
health insurance, which was financed through 
fixed income based contributions; enrolment 
was mandatory for everyone under a certain 
income level. Most of the rest of the popula-
tion (those on higher incomes) had to take 
out private insurance to get access to the 
same healthcare services. In the Netherlands 
most services are delivered by private pro-
viders and access is open for all, irrespective 
of type of insurance.
Quality of care
Health expenditure in the Netherlands as 
percentage of gross domestic product has 
been running close to the average in the 
first 15 European Union countries.1 It was 
9.8% in 2007. Overall the quality of care pro-
vided has generally been regarded as good, 
although other countries perform better on 
some clinical outcomes (box 1).
The first Dutch Health Care  Performance 
Report, which was published in 2006, 
 concluded that the Netherlands has an acces-
sible healthcare system and that utilisation 
of services is equitable, with little variation 
between different ethnic or educational 
groups.4 It also showed that healthcare 
services are within easy reach: 95% of the 
population live within 3.5 km of the nearest 
general practitioner and reported no prob-
lems in receiving timely care from primary 
care or hospital. Furthermore, less than 1% of 
 people were deterred from visiting the doc-
tor because of costs—a figure which contrasts 
with almost 12% in Germany and 25% in the 
United States.2 Dutch general practitioners 
function well as gatekeepers to secondary 
care, with low prescription and referral rates. 
About 96% of all contacts are handled within 
general practice; only 4% are referred to 
 secondary care or other primary health  care 
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Box 1 | Dutch health indicators before 2006 reforms
Doctor consultations per capita (5.4/year) and hospital discharges (10.4/1000 population) are •	
below Organisation for Economic Cooperation and Development (OECD) average (6.8 consultations 
and 16.3 discharges)2
Drug consumption (eg, antibiotics, antidepressants) is low compared with other countries•	 2
Number of caesarean sections per 100 live births is below 1 in 5; the use of coronary •	
revascularisation procedures is also low2
5.7% of patients admitted to a hospital in 2004 experienced an adverse event during their stay; 40% •	
were potentially preventable1
30 day hospital mortality for acute conditions has been decreasing since 2001 and is similar in •	
Dutch, Western, and non-Western migrants1 3
Five year survival rate for cancer in the Netherlands is above average internationally; countries such •	
as Finland, Norway, and Switzerland have better rates1 3
In 2005, the mortality for asthma was 0.11/100 000 people; the OECD average is 0.18/100 000•	 1
Countries across Europe have common health challenges but many different 
ways of tackling them.This article is part of an occasional series that looks at 
what we can learn from each other. The Dutch have opted for mandatory private 
insurance rather than a public system to cope with the challenges facing health 
care. gert Westert,  Jako Burgers, and Harry Verkleij assess how it is workingTRA
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providers.5 Compared with  countries like the 
US and Canada, the number of avoidable 
admissions is very low.6 
Nevertheless, national hospital registry and 
surveillance data show that the performance 
of providers varies substantially (eg, hospi-
tal standardised mortality rate, surgical site 
infections). Avoidable mortality (the number 
of people dying from diseases such as appen-
dicitis that could be avoided in an effective 
healthcare system3) is average and similar to 
that in Sweden, Germany, and Austria. Data 
from 2003 suggested that the Netherlands did 
not achieve the best return on its investment 
(figure). France had lower avoidable mor-
tality at the same level of expenditure, and 
Japan and Spain had even lower rates with 
lower spending. Plots of more specific output 
indicators (such as 30 day hospital mortality 
for myocardial infarction and stroke) against 
hospital expenditure per capita in various 
countries also show that the Netherlands’ 
performance is not optimal.6
2006 reforms
After lengthy debates in parliament for 
almost two decades a new Health Insur-
ance Act was approved and came into force 
in January 2006. Box 2 summarises the 
key elements of the reforms and a video is 
also available (www.minvws.nl/en/themes/
health-insurance-system/the-new-health-care-
system-in-the-Netherlands-video/).
The aim of the reforms is to encourage 
health insurers to increase the efficiency 
of health care through prudent purchase 
of health services on behalf of their enroll-
ees.9 Enrollees are given the right to change 
insurer every year, if they are dissatisfied 
with their insurer. The view is that critical 
consumers who have the right to exercise 
choice spur competition among insurers 
and insurers push healthcare providers to 
increase the quality and efficiency of their 
services.10
Under the act all insurers must offer a 
policy that provides the basic healthcare 
package benefits to anyone who applies, 
irrespective of the applicant’s age or health. 
The basic package of care is composed and 
updated annually by the government. It is 
almost comprehensive and includes primary 
care, inpatient and outpatient hospital care, 
and selected drugs. Reimbursement of dental 
and allied health care (such as physiotherapy) 
is limited but can be obtained through sup-
plementary insurance policies. The pack-
age provides essential curative care tested 
against the criteria of demonstrable efficacy, 
cost effectiveness, and the need for collective 
financing. Those who cannot afford to pay 
the monthly premiums get financial compen-
sation through the tax system. 
A fundamental element of the 2006 
reforms is the risk equalisation fund (REF).6 
Because insurers are not allowed to refuse 
unhealthy clients or people with pre-existing 
medical conditions, the government uses a 
risk adjustment tool to prevent preferred risk 
selection by insurers. The Health Care Insur-
ance Board (CVZ) is in charge of implemen-
tation. Half the money comes from income 
related employee contributions and half from 
individual premiums. The fund provides 
financial compensation to insurers for accept-
ing higher risk patients. Predictive modelling 
is used to determine each insured person’s 
expected expense. The model includes the 
following factors: age, sex, pharmacy costs, 
diagnostic cost groups, employment status, 
region, and socioeconomic status. More 
detailed information on how risk adjustment 
works is available in English on the website 
of the Ministry of Health.11 Switzerland has 
a similar equalisation scheme, but it adjusts 
risks for only age and sex.12 This universal 
mandatory insurance scheme has succeeded 
in making private insurance function for 
public benefit.13
So far so good
In the year the reforms were introduced about 
18% of people switched to a different insur-
ance company; this was appreciably higher 
than in previous years. Premiums for health 
insurance also dropped below the expected 
level of €1166 (£1000; $1700) to an aver-
age of €1142. Information about insurers 
became readily available with websites com-
paring their price and services (such as, www.
kiesbeter.nl and www.independer.nl). In the 
past three years mobility between insurance 
companies has decreased; it was below 5% in 
2007, 2008, and 2009.
One recent encouraging statistic shows that 
99% of Dutch people have taken out private 
health insurance (Statistics Netherlands, 2009). 
This figure proves that the principles of soli-
darity and equality are highly valued within 
Dutch society. The Dutch live below sea level 
behind dykes, and history has taught them that 
solidarity pays off. This solidarity has built a 
healthcare system that treats all alike. There 
is little difference in the use of care between 
people with different educational levels or eth-
nic backgrounds after differences in need have 
been taken into account. 
The reforms have led to increasing mar-
ket concentration of insurers and provid-
ers.14 Some insurers have merged, and, 
currently, five companies control 75% of the 
health insurance market. Providers (general 
practices, hospitals) are also collaborating 
within larger groups and regional networks. 
Organisational integration, with insurer and 
hospital under one roof (along the lines of US 
Box 2 | Key elements of the  
Health Insurance Act (2006)
All adults are obliged to buy health insurance •	
and can choose any insurer 
Children (under 18 years) are insured for free•	
Low income groups receive financial •	
compensation by tax reduction
All insurers must offer a (government defined) •	
policy to anyone who applies
Basic benefit package is almost •	
comprehensive
Insurers get compensation for taking on •	
higher risk patients from the risk equalisation 
fund 
Insurers can offer complementary health •	
insurance packages under free market 
conditions
Enrollees have the right to change insurer at •	
the end of every calendar year if not satisfied 
Insurers have the role of prudent purchasers •	
of health care (value for money) 
Providers are encouraged by insurers to •	
deliver high quality care at low costs
International comparison of avoidable mortality in 
people under 75 and health expenditure ($ adjusted 
for cross country price differences) in 20037 8
Health expenditure per capita ($)
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health mai ntenance organisations), has been 
explored, but so far parliament has strongly 
opposed such vertical integration, mainly 
because it would jeopardise the crucial prin-
ciple of a competitive market with insurers 
driving providers towards better performance. 
It might also complicate and limit choice for 
consumers, especially for hospital care.
The reforms also seem to be catalysing 
innovation. One of the five large insurers 
(Menzis) has recently opened primary care 
centres for its enrollees, and independent spe-
cialised treatment clinics (such as eye clinics) 
are increasing.
Insurers purchase on price
Have insurers picked up their new role of 
prudent buyers of healthcare services? The 
answer is equivocal. A joint action of large 
health insurers in June 2008 succeeded in 
negotiating huge price discounts (40–90%) 
for outpatient generic drugs. Neverthe-
less, the opportunity for insurers to pur-
chase care efficiently is limited because 
the prices and supply of health services 
are still  heavily  regulated by government. 
In the  hospital sector most prices are still 
fixed by the  government through the diag-
nosis-treatment combination system, which 
is similar to the diagnosis related groups 
used by Medicare in the US. The govern-
ment is gradually allowing free negotiation 
on the prices set for  diagnosis-treatment 
 combinations such as knee or cataract oper-
ations. In 2008,  diagnostic-treatment com-
binations  accounting for 20% of hospital 
 expenditure were made freely negotiable, 
and the  government intends to increase this 
percentage.
So far, insurers have made little use of 
quality criteria for selective contracting of 
providers.6 This is because there is limited 
valid and reliable information about where 
to go for the best care, selective contracting 
is difficult in markets without an  oversupply 
of providers, and insurers are afraid they 
will lose enrollees if they restrict consumers’ 
choice of providers.
Impact on health professionals
The introduction and reinforcing of market 
principles has led to health care becom-
ing increasingly seen as a business. Before 
2006, general practitioners were partly paid 
by capitation fees covered by social health 
insurance and partly by fees for services 
from patients who took out private insur-
ance. After 2006, the administrative bur-
den increased dramatically—for example, 
 sending (electronic) bills to the insurers. 
Billing is facilitated by a national web based 
portal, which after many teething problems 
is now up and running. As a result of the new 
contractual arrangements general practition-
ers’ income has risen since 2006.
Clinical specialists have also changed the 
way in which they work, with payment linked 
to diagnosis-treatment combinations. Their 
administrative burden has also increased but 
so has their income. Since the reforms  doctors 
have been pushed to accept  transparency as 
a tool for quality  improvement. Hospitals 
are obliged to provide information on a set 
of quality and safety indicators, and recent 
evidence shows significant improvements on 
some quality measures, such as a fall in pres-
sure ulcers.6 Measurement of individual pro-
vider’s performance is still in its infancy.
the Dutch live below sea level behind dykes, and history has taught them that solidarity  
pays off. this solidarity has built a healthcare system that treats all alike
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STATISTICAL 
quESTION
Screening  
tests II
a,d
PICTuRE quIz
A breathless woman with asthma
1  The chest radiograph shows a triangular shadow of soft tissue density behind the heart in the left lower zone. It also shows a 
loss of clarity in the adjacent descending thoracic aorta and the left hemidiaphragm in its medial portion, with depression of 
the left hilum. These features are consistent with left lower lobe collapse.
2  In a patient of this age with known asthma, the most likely cause is mucous plugging and bronchiole obstruction. In older 
patients or smokers, the most common cause of lobar collapse is a stenosing lesion secondary to bronchogenic carcinoma.
3  The patient should be admitted acutely and treated empirically with supplemental oxygen, bronchodilators, and  
steroids in accordance with national asthma guidelines. Physiotherapy should be used to dislodge the mucous plug. After 
treatment, repeat the radiograph to confirm reinflation. If the lung does not re-expand, the patient must be referred for 
urgent bronchoscopy.
ANSWErS to ENDgAmES, p 869.  For long answers use advanced search at bmj.com and enter question details 
Public opinion
Few data are available on the effect of the 
reforms on the public. National survey data 
show that summary scores on consumer 
satisfaction hardly changed between 2005 
and 2008.15 In 2005, 90.5% of the popula-
tion scored 7 or higher on the question 
“How do you judge Dutch health care in 
general?”(scale 1-10). In the three successive 
years this was 89.8%, 91.6%,  and 90.9%. In 
2005, 10.7% of the population stated that 
they “never/ sometimes” did not receive nec-
essary care compared with 9.8% in 2008.15
Bumpy road ahead
Insurers made a rational choice initially to 
focus only on price and market survival, 
but the system needs robust managed care 
by insurers on the basis of quality as well 
as price. Information about quality of health 
care counteracts market forces that are purely 
price driven. Therefore, consumers need 
more and better information about where to 
get the best care they need (such as, provider 
specific clinical indicators or patient experi-
ence measures) to make informed choices. 
The extent to which they will raise their 
voice or switch provider if this information 
becomes available is not known.
When the reforms were first introduced, 
the aim of the government was to take a back 
seat and allow market forces to operate, but 
rising healthcare costs, not least as a result of 
a rise in doctors income and volume of serv-
ices delivered, combined with the economic 
crisis may force the government to intervene. 
Recent figures from Statistics Netherlands 
indicate that health expenditure rose by 6.2% 
in 2008 compared with 5% in both 2006 and 
2007.16 “This could undermine the still imma-
ture negotiation process between insurers and 
providers and thwart insurers’ growing incli-
nation to invest in managing care.”9 Finally, if 
the trend of market concentration continues, it 
could result in higher prices and more limited 
access to health care.14 Continued close moni-
toring of the system’s quality, cost, accessibil-
ity, and outcomes is essential, as is ongoing 
comparison with other countries. The Nether-
lands has set a new path with its reform. Time 
will tell whether it will succeed.
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how different European countries are tackling their common 
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